Literature DB >> 6991465

PS-5 inhibition of a beta-lactamase from Proteus vulgaris.

K Okamura, M Sakamoto, T Ishikura.   

Abstract

Inhibition of Proteus vulgaris beta-lactamase by a new beta-lactam antibiotic, PS-5 was studied kinetically. There were two stages of inhibition. In the early stage, PS-5 inhibited the beta-lactamase by formation of a Michaelis-complex, and showed a competitive inhibition pattern with Ki-value of 0.22 microM (substrate, cephaloridine). After the formation of a Michaelis-complex between PS-5 and the enzyme, PS-5 showed a characteristic progressive inhibition pattern with time. Maximum inactivation was obtained after several minutes of preincubation of the enzyme with PS-5; as hydrolysis of PS-5 progressed, the enzyme activity was gradually recovered. Reactivation by an excess of substrate (cephaloridine) was not substantially realized in the presence of PS-5. PS-5 was very slowly hydrolyzed by the enzyme, showing a triphasic pattern in its reaction curve.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6991465     DOI: 10.7164/antibiotics.33.293

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  4 in total

Review 1.  Beta-lactamase inhibitors from laboratory to clinic.

Authors:  K Bush
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

2.  Novel carbapenem derivative SF2103A: studies on the mode of beta-lactamase inactivation.

Authors:  A Yamaguchi; T Hirata; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

3.  Kinetic studies on the inhibition of Proteus vulgaris beta-lactamase by imipenem.

Authors:  T Hashizume; A Yamaguchi; T Hirata; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

4.  6 beta-Iodopenicillanic acid (UI-38,006), a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactam compounds: initial bacteriological characterization.

Authors:  B A Moore; K W Brammer
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.